COVID-19 mRNA vaccine effectiveness (second and first booster dose) against hospitalisation and death during Omicron BA.5 circulation: cohort study based on electronic health records, Portugal, May to July 2022

被引：14
|
作者：
Kislaya, Irina [1 ,2 ]
Machado, Ausenda [1 ,2 ]
Magalhaes, Sarah
Rodrigues, Ana Paula
Franco, Rafael
Leitek, Pedro Pinto [3 ,4 ]
Dias, Carlos Matias [1 ,2 ]
Nunes, Baltazar [1 ,2 ]
机构：
[1] Inst Nacl Sailde Doutor Ricardo Jorge, Dept Epidemiol, Lisbon, Portugal
[2] Univ NOVA Lisboa, Ctr Invest Saude Publ, Escola Nacl Saude Publ, Lisbon, Portugal
[3] Serv Partilhados Minist Saude, Lisbon, Portugal
[4] Direcao Servi Informacao & Analise, Direcao Geral Saude, Lisbon, Portugal
来源：
EUROSURVEILLANCE | 2022年 / 27卷 / 37期
关键词：
D O I：
10.2807/1560-7917.ES.2022.27.37.2200697
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
We measured vaccine effectiveness (VE) against COVID-19-related severe outcomes in elderly people in Portugal between May and July 2022. In 2 80 year -olds, the second booster dose VE was 81% (95% CI: 75-85) and 82% (95% CI: 77-85), respectively, against COVID-19-related hospitalisation and death. The first booster dose VE was 63% (95% CI: 55-70) in 2 80 year -olds and 74% (95% CI: 66-80) in 60-79 year-olds against hospitalisation, and 63% (95% CI: 57-69) and 65% (95% CI: 54-74) against death.
引用
收藏
页数：6
相关论文
共 45 条
  • [41] Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
    Fabiani, Massimo
    Mateo-Urdiales, Alberto
    Sacco, Chiara
    Cristina, Maria
    Fotakis, Emmanouil Alexandros
    Petrone, Daniele
    Del Manso, Martina
    Siddu, Andrea
    Stefanelli, Paola
    Bella, Antonino
    Riccardo, Flavia
    Rezza, Giovanni
    Palamara, Anna Teresa
    Brusaferro, Silvio
    Pezzotti, Patrizio
    EUROSURVEILLANCE, 2023, 28 (32) : 2 - 8
  • [42] Covid-19 and influenza vaccine effectiveness against associated hospital admission and death among individuals over 65 years in Norway: A population-based cohort study, 3 October 2022 to 20 June 2023
    Seppala, Elina
    Dahl, Jesper
    Veneti, Lamprini
    Rydland, Kjersti Margrethe
    Kluwer, Birgitte
    Rohringer, Andreas
    Meijerink, Hinta
    VACCINE, 2024, 42 (03) : 620 - 628
  • [43] Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022
    Surie, Diya
    Bonnell, Levi
    Adams, Katherine
    Gaglani, Manjusha
    Ginde, Adit A.
    Douin, David J.
    Talbot, H. Keipp
    Casey, Jonathan D.
    Mohr, Nicholas M.
    Zepeski, Anne
    McNeal, Tresa
    Ghamande, Shekhar
    Gibbs, Kevin W.
    Files, D. Clark
    Hager, David N.
    Shehu, Arber
    Frosch, Anne P.
    Erickson, Heidi L.
    Gong, Michelle N.
    Mohamed, Amira
    Johnson, Nicholas J.
    Srinivasan, Vasisht
    Steingrub, Jay S.
    Peltan, Ithan D.
    Brown, Samuel M.
    Martin, Emily T.
    Khan, Akram
    Bender, William S.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Rivas, Carolina
    Kwon, Jennie H.
    Exline, Matthew C.
    Lauring, Adam S.
    Shapiro, Nathan I.
    Halasa, Natasha
    Chappell, James D.
    Grijalva, Carlos G.
    Rice, Todd W.
    Stubblefield, William B.
    Baughman, Adrienne
    Womack, Kelsey N.
    Hart, Kimberly W.
    Swan, Sydney A.
    Zhu, Yuwei
    DeCuir, Jennifer
    Tenforde, Mark W.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2022, 71 (42): : 1327 - 1334
  • [44] Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data
    Silva-Valencia, Javier
    Soto-Becerra, Percy
    Escobar-Agreda, Stefan
    Fernandez-Navarro, Manuel
    Elorreaga, Oliver A.
    Mayta-Tristan, Percy
    Mezones-Holguin, Edward
    Solari, Lely
    VACCINE, 2022, 40 (45) : 6512 - 6519
  • [45] Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study
    Tartof, Sara Y.
    Slezak, Jeff M.
    Puzniak, Laura
    Hong, Vennis
    Frankland, Timothy B.
    Ackerson, Bradley K.
    Xie, Fagen
    Takhar, Harpreet
    Ogun, Oluwaseye A.
    Simmons, Sarah
    Zamparo, Joann M.
    Valluri, Srinivas R.
    Jodar, Luis
    Mclaughlin, John M.
    LANCET RESPIRATORY MEDICINE, 2023, 11 (12): : 1089 - 1100
12345